From ‘start-up nation’ to ‘digital health’ nation – Implications for Asian family offices and investors in developing the Chinese ecosystem
Date and Time
30 November 2022 (Wed)
4:00pm - 5:30pm (HK Time) / 10:00am - 11:30am (Israel Time)
Language English
Format Hybrid
The Israeli life sciences and health tech sector is world renowned and home to over 1750 innovative technology companies across four major subsectors - digital health, medical devices, biotechnology and pharmaceutical therapeutics. On an annual basis, total exports of Israeli life science companies range between US$8bn to US$9bn.
The industry has grown rapidly with over 42% in digital health companies surpassing medical devices, in recent years, Israel the “start-up nation” has become the “digital health nation”, with explosive growth, now becoming the second largest hub of digital health innovation outside of the USA.
Israeli scientists and engineers have integrated advanced technologies in electronics, communications, and electro-optics to develop world-class innovations in various areas such as digital imaging, medical lasers, telemedicine, early diagnostics and smart surgical with over 750 digital health companies across the following seven sub sectors:
1. Decision support
2. Remote monitoring
3. Assistive devices
4. Digital therapeutics
5. Clinical workflow
6. Diagnostics
7. Patient engagement
Investments have increased five times in the past five years in digital health, crossing US$1.8bn of funding in 2021. In parallel to digital health, the Israeli government and Innovation Authority in the last two years has promoted a focus on bio-convergence technologies – the convergence between biotech, software and engineering. Those technologies are bringing the most advanced disruptive solutions to the medical industry and the various therapeutics areas.
We look forward to hosting you at the next Hong Kong-Israel Collaboration Workshop Series: Life Sciences and Healthcare - From ‘start-up nation’ to ‘Digital Health’ nation organised by the FSDC on 30 November 2022 (4:00pm to 5:30pm HKT).
Agenda:
|
4:00pm |
Welcome Remarks |
Peter Golovsky (See bio) Co-Lead, FSDC HK-Israel Collaboration Working Group and Managing Director, Head of Family Office Services, Asia Pacific, Alvarium |
|
4:05pm |
Keynote Address#1 |
Topic: Why Hong Kong is a key innovation hub for HealthTech & Life Science? Joseph Chan (See bio) Under Secretary for Financial Services and the Treasury HKSAR |
|
4:10pm |
Keynote Address#2 |
Lillian Cheong (See bio) Under Secretary for Innovation, Technology, and Industry HKSAR |
|
4:15pm |
Keynote Address#3 |
Topic: Israel – A global Powerhouse for Healthcare Innovation. Assaf Barnea (See bio) Founder and Managing Partner, Sanara Capital & Ventures |
|
4:35pm |
Panel Discussion |
Topic: From ‘start-up nation’ to ‘digital health’ nation – Breakthrough solutions and implications for Asian family offices and investors in developing the Chinese ecosystem of healthcare technology.
Moderator: Peter Golovsky (See bio) Co-Lead, FSDC HK-Israel Collaboration Working Group and Managing Director, Head of Family Office Services, Asia Pacific, Alvarium
Speakers: Assaf Barnea (See bio) Founder and Managing Partner, Sanara Capital & Sanara Ventures Alan Chen (See bio) President, Fosun Capital Flagship Fund Danny Farin (See bio) Co-Founder and CEO, CVAid Medical Qianli Fang (See bio) Company Secretary, M&A and Business Development Director, Sisram Medical Noam Shomron (See bio) Professor, School of Medicine, Tel Aviv University; Director, Djerassi Institute of Technology; Director, the Rare Genomics Institute - Israel Gidi Stein (See bio) Co-Founder and CEO, MedAware |
|
5:25pm |
Closing Remarks |
Amir Lati (See bio) Consul General of Israel, Hong Kong and Macau |
|
6:00pm |
End of Workshop |
Further details of the location and the agenda will be shared with you soon. Please be sure to save the date!
To get up-to-date news, research and events of the FSDC, please follow us on LinkedIn and Twitter.
Please note that, registration here is for virtual access only (Zoom). Due to social distancing requirements and the capacity of the venue, In- Person invitation only exclusively for a selected number of family office representatives and industry experts to join.
For any enquiries, please contact FSDC Market Promotion Team at event@fsdc.org.hk.